ArticleJournal of Cancer2017

Phase II Trial of Adjuvant Immunotherapy with Autologous Tumor-derived Gp96 Vaccination in Patients with Gastric Cancer.

Kecheng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.